MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brainstem encephalitis, as well as with acute disseminated encephalomyelitis (ADEM)-like presentations. Most experts now consider MOG-IgG-associated encephalomyelitis (MOG-EM) a disease entity in its own right, immunopathogenetically distinct from both classic multiple sclerosis (MS) and aquaporin-4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorders (NMOSD). Owing to a substantial overlap in clinicoradiological presentation, MOG-EM was often unwittingly misdiagnosed as MS in the past. Accordingly, increasing numbers of patients with suspected or established MS are currently being tested for MOG-IgG. However, screening of large unselected cohorts for rare biomarkers can significantly reduce the positive predictive value of a test. To lessen the hazard of overdiagnosing MOG-EM, which may lead to inappropriate treatment, more selective criteria for MOG-IgG testing are urgently needed. In this paper, we propose indications for MOG-IgG testing based on expert consensus. In addition, we give a list of conditions atypical for MOG-EM ("red flags") that should prompt physicians to challenge a positive MOG-IgG test result. Finally, we provide recommendations regarding assay methodology, specimen sampling and data interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649 · cited 1×
“[30] will meet also the criteria for MOG-IgG testing given in Table 1 and should thus be tested.”
BackgroundSelf-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Self-citationRuiter, A. M., Meilof, J. F., Somanje-Bolweg, R. R. J., van Gorsel, E., & Kalkers, N. F. (2017) · Case Reports in Neurology · doi:10.1159/000455942 · Cited by 1,762
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Self-citationDistinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Self-citationCerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
Andersson, M., Alvarez-Cermeno, J., Bernardi, G., Cogato, I., Fredman, P., Frederiksen, J., Fredrikson, S., Gallo, P., Grimaldi, L. M., Gronning, M., et al. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.897 · Cited by 741 · cited 1×
““No CSF-restricted OCB” refers to the presence of OCB patterns 1 (no OCB), 4 (mirror pattern without additional IgG bands present exclusively in the CSF), or 5 (monoclonal IgG band present both in the CSF and in the serum) [56] Some patients diagnosed with “pattern II MS” lesions, which are characterized by IgG and co…”
BackgroundClinical presentation and prognosis in MOG-antibody disease: a UK study
Jurynczyk, M., Messina, S., Woodhall, M. R., Raza, N., Everett, R., Roca-Fernandez, A., Tackley, G., Hamid, S., Sheard, A., Reynolds, G., et al. (2017) · Brain · doi:10.1093/brain/awx276 · Cited by 740
Self-citationDifferential diagnosis of suspected multiple sclerosis: a consensus approach
Miller, D., Weinshenker, B., Filippi, M., Banwell, B., Cohen, J., Freedman, M., Galetta, S., Hutchinson, M., Johnson, R., Kappos, L., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508096878 · Cited by 642
Self-citationKitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597 · cited 1×
“LETM has also been shown to be frequently present at disease onset in MOG-IgG-positive children with manifestations other than isolated ON (32/40 or 80% of all examined cases) [41] Present in 6/8 patients in [7] (at onset); 4/6 in [8]; 4/11 in [35]; 3/12 in [42]; 5/26 (not all had lumbar MRI) in [3]; and in 13/40 pedi…”
BackgroundSelf-citationOverlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis
Titulaer, M. J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L. A., Shu, H., Irioka, T., Hirano, M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24117 · Cited by 518
Self-citationMader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Self-citationMyelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Self-citationAntibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0717-1 · Cited by 429
Self-citationHacohen, Y., Wong, Y. Y., Lechner, C., Jurynczyk, M., Wright, S., Konuskan, B., Kalser, J., Poulat, A. L., Maurey, H., Ganelin-Cohen, E., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4601 · Cited by 423
Self-citationMOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Waters, P., Woodhall, M., O'Connor, K. C., Reindl, M., Lang, B., Sato, D. K., Juryńczyk, M., Tackley, G., Rocha, J., Takahashi, T., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000089 · Cited by 390
Self-citationRamanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515593406 · Cited by 384
Self-citationJarius, S., Paul, F., Franciotta, D., Ruprecht, K., Ringelstein, M., Bergamaschi, R., Rommer, P., Kleiter, I., Stich, O., Reuss, R., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.038 · Cited by 361 · cited 17×
“: Neutrophilic pleocytosis is also frequently found in AQP4-IgG-positive NMOSD [51] Observed in 43% (14/36) of MOG-IgG-positive patients with pleocytosis (peak values) [3], but only rarely in patients with MS (≤ 2% according to [52]; 1/71 patient ≥ 15 years of age [range 15–29] in [53]) Oligoclonal bands (OCB) have be…”
BackgroundInfluentialSelf-citationThe intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
Reiber, H., Ungefehr, S., & Jacobi, C. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400304 · Cited by 317
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Pröbstel, A. K., Dornmair, K., Bittner, R., Sperl, P., Jenne, D., Magalhaes, S., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 306
Self-citationHöftberger, R., Sepulveda, M., Armangue, T., Blanco, Y., Rostásy, K., Cobo Calvo, A., Olascoaga, J., Ramió-Torrentà, L., Reindl, M., Benito-León, J., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514555785 · Cited by 285
Self-citationRamanathan, S., Dale, R. C., & Brilot, F. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.12.004 · Cited by 281
Self-citationZamvil, S. S., & Slavin, A. J. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000062 · Cited by 276
Reiber, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400302 · Cited by 275
Jurynczyk, M., Geraldes, R., Probert, F., Woodhall, M. R., Waters, P., Tackley, G., DeLuca, G., Chandratre, S., Leite, M. I., Vincent, A., et al. (2017) · Brain · doi:10.1093/brain/aww350 · Cited by 265
Self-citationJarius, S., & Wildemann, B. (2013) · Brain Pathology · doi:10.1111/bpa.12084 · Cited by 254
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Kleiter, I., Ruprecht, K., Asgari, N., Pitarokoili, K., Borisow, N., Hümmert, M. W., Trebst, C., Pache, F., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0719-z · Cited by 252
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Pache, F., Zimmermann, H., Mikolajczak, J., Schumacher, S., Lacheta, A., Oertel, F. C., Bellmann-Strobl, J., Jarius, S., Wildemann, B., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0720-6 · Cited by 246
Self-citationAntibodies to MOG in adults with inflammatory demyelinating disease of the CNS
Kim, S.-M., Woodhall, M. R., Kim, J.-S., Kim, S.-J., Park, K. S., Vincent, A., Lee, K.-W., & Waters, P. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000163 · Cited by 232
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
Ramanathan, S., Reddel, S. W., Henderson, A., Parratt, J. D. E., Barnett, M., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000040 · Cited by 231
Self-citationDistinction of seropositive NMO spectrum disorder and MS brain lesion distribution
Matthews, L., Marasco, R., Jenkinson, M., Küker, W., Luppe, S., Leite, M. I., Giorgio, A., De Stefano, N., Robertson, N., Johansen-Berg, H., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182887957 · Cited by 225
Self-citationAutoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Spadaro, M., Gerdes, L. A., Krumbholz, M., Ertl-Wagner, B., Thaler, F. S., Schuh, E., Metz, I., Blaschek, A., Dick, A., Brück, W., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000257 · Cited by 206
Self-citationTemporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
Di Pauli, F., Mader, S., Rostasy, K., Schanda, K., Bajer-Kornek, B., Ehling, R., Deisenhammer, F., Reindl, M., & Berger, T. (2011) · Clinical Immunology · doi:10.1016/j.clim.2010.11.013 · Cited by 200
Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00313-0 · Cited by 180
Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
Spadaro, M., Gerdes, L. A., Mayer, M. C., Ertl-Wagner, B., Laurent, S., Krumbholz, M., Breithaupt, C., Högen, T., Straube, A., Giese, A., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.164 · Cited by 176
Self-citationBrain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
Juryńczyk, M., Tackley, G., Kong, Y., Geraldes, R., Matthews, L., Woodhall, M. R., Waters, P. J., Küker, W., Craner, M. J., Weir, A., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314005 · Cited by 165
Self-citationMariotto, S., Ferrari, S., Monaco, S., Benedetti, M. D., Schanda, K., Alberti, D., Farinazzo, A., Capra, R., Mancinelli, C., De Rossi, N., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8635-4 · Cited by 165
Peschl, P., Schanda, K., Zeka, B., Given, K., Böhm, D., Ruprecht, K., Saiz, A., Lutterotti, A., Rostásy, K., Höftberger, R., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0984-5 · Cited by 163
Self-citationChronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported
Petzold, A., & Plant, G. T. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6957-4 · Cited by 147
Jarius, S., Eichhorn, P., Franciotta, D. M., Petereit, H.-F., Akman‐Demir, G., Wick, M. W., & Wildemann, B. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8360-4 · Cited by 147
Self-citationMayer, M. C., Breithaupt, C., Reindl, M., Schanda, K., Rostásy, K., Berger, T., Dale, R. C., Brilot, F., Olsson, T., Jenne, D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301296 · Cited by 144
Self-citationMOG antibody-related disorders: common features and uncommon presentations
Cobo‐Calvo, Á., Ruiz, A., d’Indy, H., Poulat, A., Carneiro, M., Nicolas, P., Durand‐Dubief, F., Deiva, K., Vukusic, S., Portes, V. D., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8583-z · Cited by 137
Sepúlveda, M., Armangue, T., Martinez-Hernandez, E., Arrambide, G., Sola-Valls, N., Sabater, L., Téllez, N., Midaglia, L., Ariño, H., Peschl, P., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8147-7 · Cited by 130
Self-citationAnti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
Chalmoukou, K., Alexopoulos, H., Akrivou, S., Stathopoulos, P., Reindl, M., & Dalakas, M. C. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000131 · Cited by 127
Montcuquet, A., Collongues, N., Papeix, C., Zéphir, H., Audoin, B., Laplaud, D. A., Bourre, B., Brochet, B., Camdessanché, J., Labauge, P. M., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516678474 · Cited by 121
Fan, S., Xu, Y., Ren, H., Guan, H., Feng, F., Gao, X., Ding, D., Fang, F., Shan, G., Guan, T., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.01.007 · Cited by 119
Jarius, S., Metz, I., König, F. B., Ruprecht, K., Reindl, M., Paul, F., Brück, W., & Wildemann, B. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515622986 · Cited by 116
Self-citationvan Pelt, E. D., Wong, Y. Y. M., Ketelslegers, I. A., Hamann, D., & Hintzen, R. Q. (2016) · European Journal of Neurology · doi:10.1111/ene.12898 · Cited by 110
Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?
Reindl, M., Jarius, S., Rostasy, K. M., & Berger, T. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000446 · Cited by 107
Self-citationStoroni, M., Davagnanam, I., Radon, M., Siddiqui, A., & Plant, G. T. (2013) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318283c3ed · Cited by 104
Zhou, L., Huang, Y., Li, H., Fan, J., ZhangBao, J., Yu, H., Li, Y., Lu, J., Zhao, C., Lü, C., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.01.007 · Cited by 100
Mealy, M. A., Whetstone, A., Orman, G., Izbudak, I., Calabresi, P. A., & Levy, M. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.013 · Cited by 93
Self-citationBaumann, M., Grams, A. E., Djurdjevic, T., Wendel, E., Lechner, C., Behring, B., Blaschek, A., Diepold, K., Eisenkölbl, A., Fluss, J., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8781-3 · Cited by 93
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment
Cortese, A., Franciotta, D. M., Alfonsi, E., Visigalli, N., Zardini, E., Diamanti, L., Prunetti, P., Osera, C., Gastaldi, M., Berzero, G., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.022 · Cited by 92
Self-citationLesion length of optic neuritis impacts visual prognosis in neuromyelitis optica
Akaishi, T., Nakashima, I., Takeshita, T., Mugikura, S., Sato, D. K., Takahashi, T., Nishiyama, S., Kurosawa, K., Misu, T., Nakazawa, T., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.02.004 · Cited by 84
Self-citationReiber, H., Teut, M., Pohl, D., Rostasy, K. M., & Hanefeld, F. A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509348418 · Cited by 76
Jarius, S., Ruprecht, K., Stellmann, J., Huss, A. M., Ayzenberg, I., Willing, A., Trebst, C., Pawlitzki, M., Abdelhak, A., Grüter, T., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1108-6 · Cited by 67
Self-citationJarius, S., Eichhorn, P., Albert, M. H., Wagenpfeil, S., Wick, M., Belohradsky, B. H., Hohlfeld, R., Jenne, D. E., & Voltz, R. (2007) · Blood · doi:10.1182/blood-2005-12-019604 · Cited by 59
Self-citationPersistence of Immunopathological and Radiological Traits in Multiple Sclerosis
König, F. B., Wildemann, B., Nessler, S., Zhou, D., Hemmer, B., Metz, I., Hartung, H., Kieseier, B. C., & Brück, W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1527 · Cited by 46
Self-citationImmunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
Jarius, S., Franciotta, D. M., Bergamaschi, R., Wildemann, B., & Wandinger, K. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.127 · Cited by 43
Self-citationMatsuda, R., Kezuka, T., Umazume, A., Okunuki, Y., Gotô, H., & Tanaka, K. (2015) · Neuro-Ophthalmology · doi:10.3109/01658107.2015.1072726 · Cited by 39
Bouzar, M., Daoudi, S., Hattab, S., Bouzar, A. A., Deiva, K., Wildemann, B., Reindl, M., & Jarius, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3254 · Cited by 33
Self-citationTsuburaya, R. S., Miki, N., Tanaka, K., Kageyama, T., Irahara, K., Mukaida, S., Shiraishi, K., & Tanaka, M. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.02.002 · Cited by 30
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Kister, I., & Paul, F. (2015) · Neurology · doi:10.1212/wnl.0000000000001749 · Cited by 13
Self-citationMiyazaki, T., Nakajima, H., Motomura, M., Tanaka, K., Maeda, Y., Shiraishi, H., & Tsujino, A. (2016) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-000756 · Cited by 9
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Banwell, B., Bennett, J. L., Marignier, R., Kim, H. J., Brilot, F., Flanagan, E. P., Ramanathan, S., Waters, P., Tenembaum, S., Graves, J. S., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00431-8 · Cited by 1,246
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Reindl, M., & Waters, P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 626
Jarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
Self-citation
Metadata
- Authors
- Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R. C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H. J., Kleiter, I., Kümpfel, T., Levy, M., Palace, J., Ruprecht, K., Saiz, A., Trebst, C., Weinshenker, B. G., & Wildemann, B.
- Venue
- Journal of Neuroinflammation
- Published
- 2018-05-03
- Volume
- 15
- Issue
- 1
- Pages
- 134-134
- ISSN
- 1742-2094 (ISSN-L)
- OpenAlex
- W2806973999
- Cited by
- 747
- References
- 66
- FWCI
- 56.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.